ActX, Inc.
Seattle, WA, US· latest recorded location
ActX, Inc. is named on 2 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 2
- Published applications
- 4
- Inventors
- 8
- Granted in 2026 so far
- 0
- Most recent grant
- 10 Mar 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
By publication year.
Technology areas
Share of 6 documents
- A61KMedicines and medical preparations3
- A61PTherapeutic uses of medicines3
- C12NMicroorganisms or enzymes3
- G06FComputing and data processing3
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or3
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the3
- H04LDigital communication3
Recent patents
- Cloud-like medical-information service10 Mar 2020US 10,586,612 B2
- Recovery of tissue function following administration of B cells to injured tissue13 Apr 2010US 7,695,712 B2
- Cloud-like medical-information service4 Jun 2020US 2020/0176094 A1
- Cloud-like medical-information service3 Sep 2015US 2015/0248525 A1
- Recovery of Tissue Function Following Administration of B Cells to Injured Tissue21 Oct 2010US 2010/0266561 A1
- Recovery of tissue function following administration of B cells to injured tissue23 Nov 2006US 2006/0263339 A1
Most cited
By later US patents